# FDA recall D-170-2013

> **West-ward Pharmaceutical Corp.** · Class II · drug recall initiated 2013-01-07.

## Product

Belladonna Alkaloids (hyoscyamine sulfate, USP 0.1037 mg; atropine sulfate, USP 0.0194 mg; scopolamine HBr, USP 0.0065 mg) with Phenobarbital (USP 16.2 mg) Tablets, packaged in a) 1000-count tablets per bottle (NDC 0143-1140-10; b) 5000-count tablets per bottle (NDC 143-1140-51); Rx only,  Manufactured by: West-ward Pharmaceutical Corp. Eatontown, NJ 07724

## Reason for recall

Presence of Foreign Substance: Uncharacteristic blacks spots were found in tablets.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-170-2013
- **Recalling firm:** West-ward Pharmaceutical Corp.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-01-07
- **Report date:** 2013-03-06
- **Termination date:** 2015-01-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Eatontown, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-170-2013

## Citation

> AI Analytics. FDA recall D-170-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-170-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*